Clinical Implications of Androgen-Positive Triple-Negative Breast Cancer

Cancers (Basel). 2021 Apr 1;13(7):1642. doi: 10.3390/cancers13071642.

Abstract

This review summarizes the recent findings of a vast array of studies conducted on androgen receptor-positive triple-negative breast cancer (AR-positive TNBC) to provide a better understanding of this specific breast cancer subgroup. AR expression is correlated with higher age, lower histological grade, lower proliferation index Ki-67, spiculated masses, and calcifications on mammography. Studies investigating the correlation between AR expression and lymph node metastasis are highly discordant. In addition, results regarding prognosis are highly contradictory. AR antagonists are a promising novel therapeutic approach in AR-positive TNBC. However, AR signaling pathways should be more investigated in order to understand the influence of AR expression on TNBC more thoroughly.

Keywords: androgen antagonist; androgen receptor; triple-negative breast cancer.

Publication types

  • Review